Serum PSA is increased in PCa and also in benign prostatic hyperplasia (BPH), and it has limited value in distinguishing aggressive and non-aggressive cases (Etzioni et al. 2002, Finne et al. 2010, Phan et al. 2020). Here, KLK3 is linked to benign prostatic hyperplasia.